From the Journals

SABCS 2025 Highlights: Patient Perspective

Lindsay Northrop, breast cancer survivor and patient advocate at Dana-Farber, talks with Harold Burstein, MD, PhD, about how recent advances in breast cancer research presented at the 2025 San Antonio Breast Cancer Symposium will impact patient care.

  • March 17, 2026

Share

Lindsay Northrop, a breast cancer survivor and patient advocate at Dana-Farber, engages with Dr. Harold Burstein to discuss the implications of recent advancements in breast cancer research presented at the 2025 San Antonio Breast Cancer Symposium. Their conversation highlights how these breakthroughs aim to enhance patient care, with a focus on innovative treatments and their potential to improve outcomes for breast cancer patients. This dialogue emphasizes the importance of research developments in shaping future care strategies.

Original Source(s)

SABCS 2025 Highlights: Patient Perspective

  • March 17, 2026

Related Content

2025 San Antonio Breast Cancer Symposium Recap

Harold Burstein, MD, PhD, summarizes important breakthroughs presented at the 2025 San Antonio Breast Cancer Symposium.

  • March 17, 2026

SABCS 2025 Highlights: Hormone Replacement Therapy for Breast Cancer

Harold Burstein, MD, PhD, and Wendy Y. Chen, MD, MPH, discuss research in hormone replacement therapy for breast cancer that was presented at the 2025 San Antonio Breast Cancer Symposium.

  • March 17, 2026

SABCS Highlights: Advances in Oral SERD's for Breast Cancer

Harold Burstein, MD, PhD, and Rinath M. Jeselsohn, MD, discuss the lidERA, evERA, and EMBER-3 trials researching oral selective estrogen receptor degraders (SERDs).

  • March 17, 2026